Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trial.

Bao, Chunde   •   Huang, Feng   •   Khan, Muhammad Asim   •   Fei, Kaiyin   •   Wu, Zhong   •   Han, Chenglong   •   Hsia, Elizabeth C

published in: Rheumatology (Oxford, England)